Envoy Medical Inc Ordinary Shares - Class A COCH
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
New to The Street Airs This Weekend Across Bloomberg Television U.S., Latin America and MENA
-
New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results
-
New to The Street TV Announces Broadcast of Show No. 765 Tonight on Bloomberg Television at 6:30 PM ET Featuring Envoy Medical, Graphene Manufacturing Group, Rhino Bitcoin, and Big Sky Industrial
-
New to The Street to Broadcast Nationwide on Bloomberg Television Tonight at 6:30 PM ET Featuring RHINO Bitcoin, Marina Decisions, Medicus Pharma and Virtuix Holdings
-
New to The Street(R) to Broadcast Show #762 Tonight on Bloomberg Television at 6:30 PM ET, Featuring Envoy Medical (NASDAQ:COCH), AlphaCompute (NASDAQ:ALP), RHINO Bitcoin (OTC PINK:RHNO), and Big Sky Industrial (NASDAQ:BSIN)
-
New to The Street Show #761 to Broadcast Across Bloomberg U.S., Latin America and MENA, Featuring Sagtec Global, Virtuix, Lantern Pharma and YY Group
Trading Information
- Previous Close Price
- $0.68
- Day Range
- $0.65–0.69
- 52-Week Range
- $0.36–1.89
- Bid/Ask
- $0.65 / $0.68
- Shares Outstanding
- 77.39M
- Market Cap
- $50.38M
- Volume/Avg
- 6 / 164,772
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 175.71
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 47
- Website
- https://www.envoymedical.com
Valuation
|
Metric
|
COCH
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 15.21 |
Price/Sales | 175.71 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
COCH
|
|---|---|
Quick Ratio | 1.56 |
Current Ratio | 1.73 |
Interest Coverage | −48.68 |
Quick Ratio
COCH
Profitability
|
Metric
|
COCH
|
|---|---|
Return on Assets (Normalized) | −142.79% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
COCH
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|WpW$MW | LOCK|xXW& | $173B | |||
| Medtronic PLC
MDT
| LOCK|@<<^^< | LOCK|JLzd | $113B | |||
| Stryker Corp
SYK
| LOCK|cT^vg!rX | LOCK|@m | $109B | |||
| Boston Scientific Corp
BSX
| LOCK|#<!$rmb | LOCK|H&g% | $61B | |||
| Edwards Lifesciences Corp
EW
| LOCK|!jx!^zq | LOCK|?Pv& | $50B | |||
| DexCom Inc
DXCM
| LOCK|$%chRSXV | LOCK|!>?Pz | $33B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|gr%%Yf | LOCK|?h | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|K#L | LOCK|k@? | $23B | |||
| Steris PLC
STE
| LOCK|<N$lW! | LOCK|#P?@ | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|VbxP<GnM | LOCK|xyx | $17B |
United States